We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 59

China improves clinical trials and speeds up drug licensing
  • McDermott Will & Emery
  • China
  • April 5 2012

With increasing investment in research and development by foreign companies in China, assuring the reliability and efficiency of the drug and device development process is a critical priority


When is resale price maintenance legal in China?
  • McDermott Will & Emery
  • China
  • July 5 2012

A Shanghai court recently decided the first case involving vertical monopoly agreements (i.e., between supplier and distributor) since China’s Anti-Monopoly Law (AML) came into effect in 2008


China solicits comments on draft rules for writing Periodic Safety Update Reports
  • McDermott Will & Emery
  • China
  • April 10 2012

China’s State Food and Drug Administration recently issued draft guidance on drafting and preparing Periodic Safety Update Reports for drugs and is seeking comments from the public until 16 April 2012


China conditionally clears Western Digital's acquisition of Hitachi's hard disk drive business
  • McDermott Will & Emery
  • China
  • March 15 2012

Recently China’s Ministry of Commerce (MOFCOM) approved Western Digital’s proposed acquisition of Hitachi’s hard disk drive business on a conditional basis


China streamlines antitrust notification process
  • McDermott Will & Emery
  • China
  • June 27 2012

The Ministry of Commerce of China recently promulgated a new amended merger notification form along with instructions for completing the form


China summarises 2011 AML enforcement, promises action on failures to notify a concentration in 2012
  • McDermott Will & Emery
  • China
  • January 23 2012

On 27 December 2011, in its annual end-of-year press conference, the Anti-Monopoly Bureau of China’s Ministry of Commerce gave an overview of the country’s Anti-Monopoly Law enforcement efforts in 2011, as well as stated its clear intention to investigate and sanction parties who fail to submit proper notification of a concentration and have it cleared by the Ministry


China's MOFCOM now fully armed to prosecute companies failing to notify a concentration
  • McDermott Will & Emery
  • China
  • January 10 2012

China’s Ministry of Commerce (MOFCOM), following six months of public comment on and consideration of Draft Regulations, has now formally promulgated new Regulations on the Investigation & Treatment of Failure to Report a Concentration of Undertakings


China NDRC fines two pharmaceutical distributors for monopolistic practice
  • McDermott Will & Emery
  • China
  • November 21 2011

Recently, China’s National Development and Reform Commission (NDRC) imposed large fines on two pharmaceutical distributors


Impacts of criminal procedural law amendments on investigations of bribery cases
  • McDermott Will & Emery
  • China
  • May 14 2012

In a recent landmark decision, China’s national legislature, the National People’s Congress, increased the protection of suspects’ legal rights and reinforced its efforts to punish bribery and other crimes


China imposes largest fine so far on a cartel ringleader
  • McDermott Will & Emery
  • China
  • February 29 2012

China’s National Development and Reform Committee recently imposed the largest fine ever on a sodium hydrosulphite manufacturer for price fixing and other anticompetitive activities